Skip to main content
Top
Published in: Endocrine 3/2018

01-03-2018 | Review

Postpartum glucose intolerance: an updated overview

Authors: Ida Pastore, Eusebio Chiefari, Raffaella Vero, Antonio Brunetti

Published in: Endocrine | Issue 3/2018

Login to get access

Abstract

The prevalence of type 2 diabetes mellitus has increased worldwide over the past three decades, as a consequence of the more westernized lifestyle, which is responsible for the increasing obesity rate in the modern adult’s life. Concomitant with this increase there has been a gradual rise in the overall prevalence of gestational diabetes mellitus, a condition that strongly predisposes to overt diabetes later in life. Many women with previous gestational diabetes mellitus show glucose intolerance in the early postpartum period. Although the best screening strategy for postpartum glucose intolerance is still debated, numerous evidences indicate that identification of these women at this time is of critical importance, as efforts to initiate early intensive lifestyle modification, including hypocaloric diet and physical activity, and to ameliorate the metabolic profile of these high-risk subjects can prevent or delay the onset of type 2 diabetes mellitus. Nevertheless, less than one fifth of women attend the scheduled postpartum screening following gestational diabetes mellitus and they are at increased risk to develop type 2 diabetes mellitus later in their lives. Unsatisfying results have also come from early intervention strategies and tools that have been developed during the last few years to help improving the rate of adherence to postpartum glycemic testing, thereby indicating that more effective strategies are needed to improve women’s participation in postpartum screening.
Literature
1.
go back to reference American Diabetes Association, Standards of medical care in diabetes–2015, 2. Classification and diagnosis of diabetes. Diabetes Care 38(Suppl 1), S8–S16 (2015)CrossRef American Diabetes Association, Standards of medical care in diabetes–2015, 2. Classification and diagnosis of diabetes. Diabetes Care 38(Suppl 1), S8–S16 (2015)CrossRef
2.
go back to reference R.E. Ratner, C.A. Cristophi, B.E. Metzger, D. Dabelea, P.H. Bennett, X. Pi-Sunyer, S. Fowler, S.E. Kahn, Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J. Clin. Endocrinol. Metab. 93(12), 4774–4779 (2008)PubMedPubMedCentralCrossRef R.E. Ratner, C.A. Cristophi, B.E. Metzger, D. Dabelea, P.H. Bennett, X. Pi-Sunyer, S. Fowler, S.E. Kahn, Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J. Clin. Endocrinol. Metab. 93(12), 4774–4779 (2008)PubMedPubMedCentralCrossRef
3.
go back to reference International Association of Diabetes and Pregnancy Study Groups Consensus Panel, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3), 676–682 (2010)PubMedCentralCrossRef International Association of Diabetes and Pregnancy Study Groups Consensus Panel, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3), 676–682 (2010)PubMedCentralCrossRef
4.
go back to reference R. Retnakaran, Y. Qi, P.W. Connelly, M. Sermer, A.J. Hanley, B. Zinman, Risk of early progression to prediabetes or diabetes in women with recent gestational dysglycaemia but normal glucose tolerance at 3-month postpartum. Clin. Endocrinol. 73(4), 476–483 (2010) R. Retnakaran, Y. Qi, P.W. Connelly, M. Sermer, A.J. Hanley, B. Zinman, Risk of early progression to prediabetes or diabetes in women with recent gestational dysglycaemia but normal glucose tolerance at 3-month postpartum. Clin. Endocrinol. 73(4), 476–483 (2010)
5.
go back to reference R. Retnakaran, B.R. Shah, Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet. Med. 26(5), 474–477 (2009)PubMedCrossRef R. Retnakaran, B.R. Shah, Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet. Med. 26(5), 474–477 (2009)PubMedCrossRef
6.
go back to reference R. Retnakaran, Y. Qi, M. Sermer, P.W. Connelly, A.J. Hanley, B. Zinman, Glucose intolerance in pregnancy and future risk of prediabetes or diabetes. Diabetes Care 31(10), 2026–2031 (2008)PubMedPubMedCentralCrossRef R. Retnakaran, Y. Qi, M. Sermer, P.W. Connelly, A.J. Hanley, B. Zinman, Glucose intolerance in pregnancy and future risk of prediabetes or diabetes. Diabetes Care 31(10), 2026–2031 (2008)PubMedPubMedCentralCrossRef
7.
go back to reference A. Vambergue, C. Dognin, A. Boulogne, M.C. Réjou, S. Biausque, P. Fontaine, Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study. Diabet. Med. 25(1), 58–64 (2008)PubMed A. Vambergue, C. Dognin, A. Boulogne, M.C. Réjou, S. Biausque, P. Fontaine, Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study. Diabet. Med. 25(1), 58–64 (2008)PubMed
8.
go back to reference D.B. Carr, K.M. Newton, K.M. Utzschneider, J. Tong, F. Gerchman, S.E. Kahn, S.R. Heckbert, Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus. Diabetes Care 31(5), 1037–1039 (2008)PubMedCrossRef D.B. Carr, K.M. Newton, K.M. Utzschneider, J. Tong, F. Gerchman, S.E. Kahn, S.R. Heckbert, Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus. Diabetes Care 31(5), 1037–1039 (2008)PubMedCrossRef
9.
go back to reference J.M. Lawrence, R. Contreras, W. Chen, D.A. Sacks, Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005. Diabetes Care 31(5), 899–904 (2008)PubMedCrossRef J.M. Lawrence, R. Contreras, W. Chen, D.A. Sacks, Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005. Diabetes Care 31(5), 899–904 (2008)PubMedCrossRef
11.
go back to reference G. Danaei, M.M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, C.J. Paciorek, J.K. Lin, F. Farzadfar, Y.H. Khang, G.A. Stevens, M. Rao, M.K. Ali, L.M. Riley, C.A. Robinson, M. Ezzati, National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378(9785), 31–40 (2011)PubMedCrossRef G. Danaei, M.M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, C.J. Paciorek, J.K. Lin, F. Farzadfar, Y.H. Khang, G.A. Stevens, M. Rao, M.K. Ali, L.M. Riley, C.A. Robinson, M. Ezzati, National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378(9785), 31–40 (2011)PubMedCrossRef
12.
go back to reference S. Wild, G. Roglic, A. Green, R. Sicree, H. King, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5), 1047–1053 (2004)PubMedCrossRef S. Wild, G. Roglic, A. Green, R. Sicree, H. King, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5), 1047–1053 (2004)PubMedCrossRef
13.
go back to reference K. Ogurtsova, J.D. da Rocha Fernandes, Y. Huang, U. Linnenkamp, L. Guariguata, N.H. Cho, D. Cavan, J.E. Shaw, L.E. Makaroff, IDF diabetes atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 128, 40–50 (2017)PubMedCrossRef K. Ogurtsova, J.D. da Rocha Fernandes, Y. Huang, U. Linnenkamp, L. Guariguata, N.H. Cho, D. Cavan, J.E. Shaw, L.E. Makaroff, IDF diabetes atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 128, 40–50 (2017)PubMedCrossRef
15.
go back to reference S. Genuth, K.G. Alberti, P. Bennett, J. Buse, R. Defronzo, R. Kahn, J. Kitzmiller, W.C. Knowler, H. Lebovitz, A. Lernmark, D. Nathan, J. Palmer, R. Rizza, C. Saudek, J. Shaw, M. Steffes, M. Stern, J. Tuomilehto, P. Zimmet, Expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(11), 3160–3167 (2003)PubMedCrossRef S. Genuth, K.G. Alberti, P. Bennett, J. Buse, R. Defronzo, R. Kahn, J. Kitzmiller, W.C. Knowler, H. Lebovitz, A. Lernmark, D. Nathan, J. Palmer, R. Rizza, C. Saudek, J. Shaw, M. Steffes, M. Stern, J. Tuomilehto, P. Zimmet, Expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(11), 3160–3167 (2003)PubMedCrossRef
16.
go back to reference X. Zhang, E.W. Gregg, D.F. Williamson, L.E. Barker, W. Thomas, K.M. Bullard, G. Imperatore, D.E. Williams, A.L. Albright, A1C level and future risk of diabetes: a systematic review. Diabetes Care 33(7), 1665–1673 (2010)PubMedPubMedCentralCrossRef X. Zhang, E.W. Gregg, D.F. Williamson, L.E. Barker, W. Thomas, K.M. Bullard, G. Imperatore, D.E. Williams, A.L. Albright, A1C level and future risk of diabetes: a systematic review. Diabetes Care 33(7), 1665–1673 (2010)PubMedPubMedCentralCrossRef
17.
go back to reference American Diabetes Association, Standards of medical care in diabetes–2017, 2. Classification and diagnosis of diabetes. Diabetes Care 40(Suppl 1), S11–S24 (2017)CrossRef American Diabetes Association, Standards of medical care in diabetes–2017, 2. Classification and diagnosis of diabetes. Diabetes Care 40(Suppl 1), S11–S24 (2017)CrossRef
18.
go back to reference K.J. Hunt, K.L. Schuller, The increasing prevalence of diabetes in pregnancy. Obstet. Gynecol. Clin. N. Am. 34(2), 173–199 (2007)CrossRef K.J. Hunt, K.L. Schuller, The increasing prevalence of diabetes in pregnancy. Obstet. Gynecol. Clin. N. Am. 34(2), 173–199 (2007)CrossRef
19.
go back to reference L. Bellamy, J.P. Casas, A.D. Hingorani, D. Williams, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta–analysis. Lancet 373(9677), 1773–1779 (2009)PubMedCrossRef L. Bellamy, J.P. Casas, A.D. Hingorani, D. Williams, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta–analysis. Lancet 373(9677), 1773–1779 (2009)PubMedCrossRef
20.
go back to reference D.S. Feig, B. Zinman, X. Wang, J.E. Hux, Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179(3), 229–234 (2008)PubMedPubMedCentralCrossRef D.S. Feig, B. Zinman, X. Wang, J.E. Hux, Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179(3), 229–234 (2008)PubMedPubMedCentralCrossRef
21.
go back to reference C. Kim, K.M. Newton, R.H. Knopp, Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10), 1862–1868 (2002)PubMedCrossRef C. Kim, K.M. Newton, R.H. Knopp, Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10), 1862–1868 (2002)PubMedCrossRef
22.
go back to reference J. Lauenborg, T. Hansen, D.M. Jensen, H. Vestergaard, L. Molsted-Pedersen, P. Hornnes, H. Locht, O. Pedersen, P. Damm, Increasing incidence of diabetes after gestational diabetes: a long-term follow- up in a Danish population. Diabetes Care 27(5), 1194–1199 (2004)PubMedCrossRef J. Lauenborg, T. Hansen, D.M. Jensen, H. Vestergaard, L. Molsted-Pedersen, P. Hornnes, H. Locht, O. Pedersen, P. Damm, Increasing incidence of diabetes after gestational diabetes: a long-term follow- up in a Danish population. Diabetes Care 27(5), 1194–1199 (2004)PubMedCrossRef
23.
go back to reference M. Stumvoll, B.J. Goldstein, T.W. van Haeften, Type 2 diabetes: pathogenesis and treatment. Lancet 371(9631), 2153–2156 (2008)PubMedCrossRef M. Stumvoll, B.J. Goldstein, T.W. van Haeften, Type 2 diabetes: pathogenesis and treatment. Lancet 371(9631), 2153–2156 (2008)PubMedCrossRef
24.
go back to reference G. Willemsen, K.J. Ward, C.G. Bell, K. Christensen, J. Bowden, C. Dalgård, J.R. Harris, J. Kaprio, R. Lyle, P.K. Magnusson, K.A. Mather, J.R. Ordoňana, F. Perez-Riquelme, N.L. Pedersen, K.H. Pietiläinen, P.S. Sachdev, D.I. Boomsma, T. Spector, The concordance and heritability of type 2 diabetes in 34,166 twin pairs from international twin registers: the discordant twin (DISCOTWIN) consortium. Twin. Res. Hum. Genet. 18(6), 762–771 (2015)PubMedCrossRef G. Willemsen, K.J. Ward, C.G. Bell, K. Christensen, J. Bowden, C. Dalgård, J.R. Harris, J. Kaprio, R. Lyle, P.K. Magnusson, K.A. Mather, J.R. Ordoňana, F. Perez-Riquelme, N.L. Pedersen, K.H. Pietiläinen, P.S. Sachdev, D.I. Boomsma, T. Spector, The concordance and heritability of type 2 diabetes in 34,166 twin pairs from international twin registers: the discordant twin (DISCOTWIN) consortium. Twin. Res. Hum. Genet. 18(6), 762–771 (2015)PubMedCrossRef
25.
go back to reference A. Brunetti, E. Chiefari, D. Foti, Perspectives on the contribution of genetics to the pathogenesis of type 2 diabetes mellitus. Recenti. Prog. Med. 102(12), 468–475 (2011)PubMed A. Brunetti, E. Chiefari, D. Foti, Perspectives on the contribution of genetics to the pathogenesis of type 2 diabetes mellitus. Recenti. Prog. Med. 102(12), 468–475 (2011)PubMed
26.
go back to reference C.R. Pullinger, I.D. Goldfine, S. Tanyolaç, I. Movsesyan, M. Faynboym, V. Durlach, E. Chiefari, D.P. Foti, P.H. Frost, M.J. Malloy, A. Brunetti, J.P. Kane, Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population. Metab. Syndr. Relat. Disord. 12(1), 25–30 (2014)PubMedCrossRef C.R. Pullinger, I.D. Goldfine, S. Tanyolaç, I. Movsesyan, M. Faynboym, V. Durlach, E. Chiefari, D.P. Foti, P.H. Frost, M.J. Malloy, A. Brunetti, J.P. Kane, Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population. Metab. Syndr. Relat. Disord. 12(1), 25–30 (2014)PubMedCrossRef
27.
go back to reference E. Chiefari, S. Tanyolaç, S. Iiritano, A. Sciacqua, C. Capula, B. Arcidiacono, A. Nocera, K. Possidente, F. Baudi, V. Ventura, G. Brunetti, F.S. Brunetti, R. Vero, R. Maio, M. Greco, M. Pavia, U. Hodoglugil, V. Durlach, C.R. Pullinger, I.D. Goldfine, F. Perticone, D. Foti, A. Brunetti, A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci. Rep. 3, 1491 (2013)PubMedPubMedCentralCrossRef E. Chiefari, S. Tanyolaç, S. Iiritano, A. Sciacqua, C. Capula, B. Arcidiacono, A. Nocera, K. Possidente, F. Baudi, V. Ventura, G. Brunetti, F.S. Brunetti, R. Vero, R. Maio, M. Greco, M. Pavia, U. Hodoglugil, V. Durlach, C.R. Pullinger, I.D. Goldfine, F. Perticone, D. Foti, A. Brunetti, A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci. Rep. 3, 1491 (2013)PubMedPubMedCentralCrossRef
29.
go back to reference H. Liu, C. Zhang, S. Zhang, L. Wang, J. Leng, D. Liu, H. Fang, W. Li, Z. Yu, X. Yang, L. Dong, G. Hu, Prepregnancy body mass index and weight change on postpartum diabetes risk among gestational diabetes women. Obesity 22(6), 1560–1567 (2014)PubMedCrossRef H. Liu, C. Zhang, S. Zhang, L. Wang, J. Leng, D. Liu, H. Fang, W. Li, Z. Yu, X. Yang, L. Dong, G. Hu, Prepregnancy body mass index and weight change on postpartum diabetes risk among gestational diabetes women. Obesity 22(6), 1560–1567 (2014)PubMedCrossRef
30.
go back to reference S. Kwak, S.H. Choi, K. Kim, H.S. Jung, Y.M. Cho, S. Lim, N.H. Cho, S.Y. Kim, K.S. Park, H.C. Jang, Prediction of type 2 diabetes in women with a history of gestational diabetes using a genetic risk score. Diabetologia 56(12), 2556–2563 (2013)PubMedCrossRef S. Kwak, S.H. Choi, K. Kim, H.S. Jung, Y.M. Cho, S. Lim, N.H. Cho, S.Y. Kim, K.S. Park, H.C. Jang, Prediction of type 2 diabetes in women with a history of gestational diabetes using a genetic risk score. Diabetologia 56(12), 2556–2563 (2013)PubMedCrossRef
31.
go back to reference S.H. Kim, M.Y. Kim, J.H. Yang, S.Y. Park, C.H. Yim, K.O. Han, H.K. Yoon, S. Park, Nutritional risk factors of early development of postpartum prediabetes and diabetes in women with gestational diabetes mellitus. Nutrition 27(7-8), 782–788 (2011)PubMedCrossRef S.H. Kim, M.Y. Kim, J.H. Yang, S.Y. Park, C.H. Yim, K.O. Han, H.K. Yoon, S. Park, Nutritional risk factors of early development of postpartum prediabetes and diabetes in women with gestational diabetes mellitus. Nutrition 27(7-8), 782–788 (2011)PubMedCrossRef
32.
go back to reference W. Bao, E. Yeung, D.K. Tobias, F.B. Hu, A.A. Vaag, J.E. Chavarro, J.L. Mills, L.G. Grunnet, K. Bowers, S.H. Ley, M. Kiely, S.F. Olsen, C. Zhang, Long-term risk of type 2 diabetes mellitus in relation to BMI and weight change among women with a history of gestational diabetes mellitus: a prospective cohort study. Diabetologia 58(6), 1212–1219 (2015)PubMedPubMedCentralCrossRef W. Bao, E. Yeung, D.K. Tobias, F.B. Hu, A.A. Vaag, J.E. Chavarro, J.L. Mills, L.G. Grunnet, K. Bowers, S.H. Ley, M. Kiely, S.F. Olsen, C. Zhang, Long-term risk of type 2 diabetes mellitus in relation to BMI and weight change among women with a history of gestational diabetes mellitus: a prospective cohort study. Diabetologia 58(6), 1212–1219 (2015)PubMedPubMedCentralCrossRef
33.
go back to reference A.H. Xiang, M. Kawakubo, E. Trigo, S.L. Kjos, T.A. Buchanan, Declining beta-cell compensation for insulin resistance in hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein. Diabetes Care 33(2), 396–401 (2010)PubMedCrossRef A.H. Xiang, M. Kawakubo, E. Trigo, S.L. Kjos, T.A. Buchanan, Declining beta-cell compensation for insulin resistance in hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein. Diabetes Care 33(2), 396–401 (2010)PubMedCrossRef
34.
go back to reference B. Arcidiacono, S. Iiritano, E. Chiefari, F.S. Brunetti, G. Gu, D.P. Foti, A. Brunetti, Cooperation between HMGA1, PDX-1, and MafA is Essential for glucose-induced insulin transcription in pancreatic beta cells. Front. Endocrinol. 13(5), 237 (2015) B. Arcidiacono, S. Iiritano, E. Chiefari, F.S. Brunetti, G. Gu, D.P. Foti, A. Brunetti, Cooperation between HMGA1, PDX-1, and MafA is Essential for glucose-induced insulin transcription in pancreatic beta cells. Front. Endocrinol. 13(5), 237 (2015)
35.
go back to reference N. Samaan, S.C.C. Yen, D. Gonzalez, O.H. Pearson, Metabolic effects of placental lactogen (HPL) in man. J. Clin. Endocrinol. Metab. 28(4), 485–491 (1968)PubMedCrossRef N. Samaan, S.C.C. Yen, D. Gonzalez, O.H. Pearson, Metabolic effects of placental lactogen (HPL) in man. J. Clin. Endocrinol. Metab. 28(4), 485–491 (1968)PubMedCrossRef
36.
go back to reference G. Di Cianni, R. Miccoli, L. Volpe, C. Lencioni, S. Del Prato, Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab. Res. Rev. 19(4), 259–270 (2003)PubMedCrossRef G. Di Cianni, R. Miccoli, L. Volpe, C. Lencioni, S. Del Prato, Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab. Res. Rev. 19(4), 259–270 (2003)PubMedCrossRef
37.
go back to reference C. Kühl, P.J. Hornnes, O. Andersen, Etiology and pathophysiology of gestational diabetes mellitus. Diabetes 34(Suppl 2), 66–70 (1985)PubMedCrossRef C. Kühl, P.J. Hornnes, O. Andersen, Etiology and pathophysiology of gestational diabetes mellitus. Diabetes 34(Suppl 2), 66–70 (1985)PubMedCrossRef
38.
go back to reference M. Ekelund, N. Shaat, P. Almgren, E. Anderberg, M. Landin-Olsson, V. Lyssenko, L. Groop, K. Berntorp, Genetic prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 97(3), 394–398 (2012)PubMedCrossRef M. Ekelund, N. Shaat, P. Almgren, E. Anderberg, M. Landin-Olsson, V. Lyssenko, L. Groop, K. Berntorp, Genetic prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 97(3), 394–398 (2012)PubMedCrossRef
39.
go back to reference S.L. Kjos, R.K. Peters, A. Xiang, D. Thomas, U. Schaefer, T.A. Buchanan, Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 280(6), 533–538 (1998)PubMedCrossRef S.L. Kjos, R.K. Peters, A. Xiang, D. Thomas, U. Schaefer, T.A. Buchanan, Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 280(6), 533–538 (1998)PubMedCrossRef
40.
go back to reference A.H. Xiang, M. Kawakubo, S.L. Kjos, T.A. Buchanan, Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 29(3), 613–617 (2006)PubMedCrossRef A.H. Xiang, M. Kawakubo, S.L. Kjos, T.A. Buchanan, Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 29(3), 613–617 (2006)PubMedCrossRef
41.
go back to reference C. Kim, K.W. Seidel, E.A. Begier, Y.S. Kwok, Diabetes and depot medroxyprogesterone contraception in Navajo women. Arch. Intern. Med. 161(14), 1766–1771 (2001)PubMedCrossRef C. Kim, K.W. Seidel, E.A. Begier, Y.S. Kwok, Diabetes and depot medroxyprogesterone contraception in Navajo women. Arch. Intern. Med. 161(14), 1766–1771 (2001)PubMedCrossRef
42.
go back to reference R.K. Peters, S.L. Kjos, A. Xiang, T.A. Buchanan, Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 347(8996), 227–230 (1996)PubMedCrossRef R.K. Peters, S.L. Kjos, A. Xiang, T.A. Buchanan, Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 347(8996), 227–230 (1996)PubMedCrossRef
43.
go back to reference A.H. Xiang, S.L. Kjos, M. Takayanagi, E. Trigo, T.A. Buchanan, Detailed physiological characterization of the development of type 2 diabetes in hispanic women with prior gestational diabetes mellitus. Diabetes 59(10), 2625–2630 (2010)PubMedPubMedCentralCrossRef A.H. Xiang, S.L. Kjos, M. Takayanagi, E. Trigo, T.A. Buchanan, Detailed physiological characterization of the development of type 2 diabetes in hispanic women with prior gestational diabetes mellitus. Diabetes 59(10), 2625–2630 (2010)PubMedPubMedCentralCrossRef
44.
go back to reference M.G. Dalfrà, A. Lapolla, M. Masin, G. Giglia, B. Dalla Barba, R. Toniato, D. Fedele, Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus. Diabetes Metab. 27(6), 675–680 (2001)PubMed M.G. Dalfrà, A. Lapolla, M. Masin, G. Giglia, B. Dalla Barba, R. Toniato, D. Fedele, Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus. Diabetes Metab. 27(6), 675–680 (2001)PubMed
47.
go back to reference M. Rottenkolber, U. Ferrari, L. Holland, S. Aertsen, N.N. Kammer, H. Hetterich, M. Fugmann, F. Banning, M. Weise, V. Sacco, D. Kohn, I. Freibothe, S. Hutter, U. Hasbargen, R. Lehmann, H. Grallert, K.G. Parhofer, J. Seissler, A. Lechner, The diabetes risk phenotype of young women with recent gestational diabetes. J. Clin. Endocrinol. Metab. 100(6), E910–E918 (2015)PubMedCrossRef M. Rottenkolber, U. Ferrari, L. Holland, S. Aertsen, N.N. Kammer, H. Hetterich, M. Fugmann, F. Banning, M. Weise, V. Sacco, D. Kohn, I. Freibothe, S. Hutter, U. Hasbargen, R. Lehmann, H. Grallert, K.G. Parhofer, J. Seissler, A. Lechner, The diabetes risk phenotype of young women with recent gestational diabetes. J. Clin. Endocrinol. Metab. 100(6), E910–E918 (2015)PubMedCrossRef
48.
go back to reference T.A. Buchanan, A.H. Xiang, R.K. Peters, S.L. Kjos, A. Marroquin, J. Goico, C. Ochoa, S. Tan, K. Berkowitz, H.N. Hodis, S.P. Azen, Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51(9), 2796–2803 (2002)PubMedCrossRef T.A. Buchanan, A.H. Xiang, R.K. Peters, S.L. Kjos, A. Marroquin, J. Goico, C. Ochoa, S. Tan, K. Berkowitz, H.N. Hodis, S.P. Azen, Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51(9), 2796–2803 (2002)PubMedCrossRef
49.
go back to reference J. Tuomilehto, J. Lindström, J.G. Eriksson, T.T. Valle, H. Hämäläinen, P. Ilanne-Parikka, S. Keinänen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Rastas, V. Salminen, M. Uusitupa, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344(18), 1343–1350 (2001)PubMedCrossRef J. Tuomilehto, J. Lindström, J.G. Eriksson, T.T. Valle, H. Hämäläinen, P. Ilanne-Parikka, S. Keinänen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Rastas, V. Salminen, M. Uusitupa, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344(18), 1343–1350 (2001)PubMedCrossRef
50.
go back to reference W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan; Diabetes Prevention Program Research Group, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393–403 (2002)PubMedCrossRef W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan; Diabetes Prevention Program Research Group, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393–403 (2002)PubMedCrossRef
51.
go back to reference L. Leuridan, J. Wens, R. Devlieger, J. Verhaeghe, C. Mathieu, K. Benhalima, Glucose intolerance in early postpartum in women with gestational diabetes: Who is at increased risk? Prim. Care Diabetes 9(4), 244–252 (2015)PubMedCrossRef L. Leuridan, J. Wens, R. Devlieger, J. Verhaeghe, C. Mathieu, K. Benhalima, Glucose intolerance in early postpartum in women with gestational diabetes: Who is at increased risk? Prim. Care Diabetes 9(4), 244–252 (2015)PubMedCrossRef
52.
go back to reference G. Rayanagoudar, A.A. Hashi, J. Zamora, K.S. Khan, G.A. Hitman, S. Thangaratinam, Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women. Diabetologia 59(7), 1403–1411 (2016)PubMedPubMedCentralCrossRef G. Rayanagoudar, A.A. Hashi, J. Zamora, K.S. Khan, G.A. Hitman, S. Thangaratinam, Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women. Diabetologia 59(7), 1403–1411 (2016)PubMedPubMedCentralCrossRef
53.
go back to reference S.H. Golden, W.L. Bennett, K. Baptist-Roberts, L.M. Wilson, B. Barone, T.L. Gary, E. Bass, W.K. Nicholson, Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review. Gend. Med. 6(Suppl 1), 109–122 (2009)PubMedCrossRef S.H. Golden, W.L. Bennett, K. Baptist-Roberts, L.M. Wilson, B. Barone, T.L. Gary, E. Bass, W.K. Nicholson, Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review. Gend. Med. 6(Suppl 1), 109–122 (2009)PubMedCrossRef
54.
go back to reference K. Tanase-Nakao, N. Arata, M. Kawasaki, I. Yasuhi, H. Sone, R. Mori, E. Ota, Potential protective effect of lactation against incidence of type 2 diabetes mellitusin women with previous gestational diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab. Res. Rev. (2017). doi:10.1002/dmrr.2875 PubMedCentralCrossRef K. Tanase-Nakao, N. Arata, M. Kawasaki, I. Yasuhi, H. Sone, R. Mori, E. Ota, Potential protective effect of lactation against incidence of type 2 diabetes mellitusin women with previous gestational diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab. Res. Rev. (2017). doi:​10.​1002/​dmrr.​2875 PubMedCentralCrossRef
55.
go back to reference Z. Wang, Z. Wang, L. Wang, M. Qiu, Y. Wang, X. Hou, Z. Guo, B. Wang, Hypertensive disorders during pregnancy and risk of type 2 diabetes in later life: a systematic review and meta-analysis. Endocrine 55(3), 809–821 (2017)PubMedCrossRef Z. Wang, Z. Wang, L. Wang, M. Qiu, Y. Wang, X. Hou, Z. Guo, B. Wang, Hypertensive disorders during pregnancy and risk of type 2 diabetes in later life: a systematic review and meta-analysis. Endocrine 55(3), 809–821 (2017)PubMedCrossRef
56.
go back to reference F. Pallardo, L. Herranz, T. Garcia-Ingelmo, C. Grande, P. Martin-Vaquero, M. Jañez, A. Gonzalez, Early postpartum metabolic assessment with prior gestational diabetes. Diabetes Care 22(7), 1053–1058 (1999)PubMedCrossRef F. Pallardo, L. Herranz, T. Garcia-Ingelmo, C. Grande, P. Martin-Vaquero, M. Jañez, A. Gonzalez, Early postpartum metabolic assessment with prior gestational diabetes. Diabetes Care 22(7), 1053–1058 (1999)PubMedCrossRef
57.
go back to reference T.A. Buchanan, A. Xiang, S.L. Kjos, W.P. Lee, E. Trigo, I. Nader, E.A. Bergner, J.P. Palmer, R.K. Peters, Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes 47(8), 1302–1310 (1998)PubMedCrossRef T.A. Buchanan, A. Xiang, S.L. Kjos, W.P. Lee, E. Trigo, I. Nader, E.A. Bergner, J.P. Palmer, R.K. Peters, Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes 47(8), 1302–1310 (1998)PubMedCrossRef
58.
go back to reference N. Kojima, K. Tanimura, M. Deguchi, M. Morizane, Y. Hirota, W. Ogawa, H. Yamada, Risk factors for postpartum glucose intolerance in women with gestational diabetes mellitus. Gynecol. Endocrinol. 32(10), 803–806 (2016)PubMedCrossRef N. Kojima, K. Tanimura, M. Deguchi, M. Morizane, Y. Hirota, W. Ogawa, H. Yamada, Risk factors for postpartum glucose intolerance in women with gestational diabetes mellitus. Gynecol. Endocrinol. 32(10), 803–806 (2016)PubMedCrossRef
59.
go back to reference H.C. Jang, C.H. Yim, K.O. Han, H.K. Yoon, I.K. Han, M.Y. Kim, J.H. Yang, N.H. Cho, Gestational diabetes mellitus in Korea: prevalence and prediction of glucose intolerance at early postpartum. Diabetes Res. Clin. Pract. 61(2), 117–124 (2003)PubMedCrossRef H.C. Jang, C.H. Yim, K.O. Han, H.K. Yoon, I.K. Han, M.Y. Kim, J.H. Yang, N.H. Cho, Gestational diabetes mellitus in Korea: prevalence and prediction of glucose intolerance at early postpartum. Diabetes Res. Clin. Pract. 61(2), 117–124 (2003)PubMedCrossRef
60.
go back to reference C. Capula, E. Chiefari, A. Vero, D.P. Foti, A. Brunetti, R. Vero, Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 105(2), 223–230 (2014)PubMedCrossRef C. Capula, E. Chiefari, A. Vero, D.P. Foti, A. Brunetti, R. Vero, Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 105(2), 223–230 (2014)PubMedCrossRef
61.
go back to reference J.L. Kitzmiller, L. Dang-Kilduff, M.M. Taslimi, Gestational diabetes after delivery. Short-term management and long-term risks. Diabetes Care 30(Suppl. 2), S225–S235 (2007)PubMedCrossRef J.L. Kitzmiller, L. Dang-Kilduff, M.M. Taslimi, Gestational diabetes after delivery. Short-term management and long-term risks. Diabetes Care 30(Suppl. 2), S225–S235 (2007)PubMedCrossRef
62.
go back to reference L.F. Pallardo, L. Herranz, P. Martin-Vaquero, T. Garcia-Ingelmo, C. Grande, M. Jañez, Impaired fasting glucose and impaired glucose tolerance in women with prior gestational diabetes are associated with a different cardiovascular profile. Diabetes Care 28(8), 2318–2322 (2003)CrossRef L.F. Pallardo, L. Herranz, P. Martin-Vaquero, T. Garcia-Ingelmo, C. Grande, M. Jañez, Impaired fasting glucose and impaired glucose tolerance in women with prior gestational diabetes are associated with a different cardiovascular profile. Diabetes Care 28(8), 2318–2322 (2003)CrossRef
63.
go back to reference J.L. Kitzmiller, T.A. Buchanan, S. Kjos, C.A. Combs, R.E. Ratner, Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 19(5), 514–541 (1996)PubMedCrossRef J.L. Kitzmiller, T.A. Buchanan, S. Kjos, C.A. Combs, R.E. Ratner, Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 19(5), 514–541 (1996)PubMedCrossRef
64.
go back to reference T. Farrell, L. Neale, T. Cindy, Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet. Med. 19(4), 322–326 (2002)PubMedCrossRef T. Farrell, L. Neale, T. Cindy, Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet. Med. 19(4), 322–326 (2002)PubMedCrossRef
65.
go back to reference B.E. Metzger, T.A. Buchanan, D.R. Coustan, A. de Leiva, D.B. Dunger, D.R. Hadden, M. Hod, J.L. Kitzmiller, S.L. Kjos, J.N. Oats, D.J. Pettitt, D.A. Sacks, C. Zoupas, Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care 30(Suppl. 2), S251–S260 (2007)CrossRefPubMed B.E. Metzger, T.A. Buchanan, D.R. Coustan, A. de Leiva, D.B. Dunger, D.R. Hadden, M. Hod, J.L. Kitzmiller, S.L. Kjos, J.N. Oats, D.J. Pettitt, D.A. Sacks, C. Zoupas, Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care 30(Suppl. 2), S251–S260 (2007)CrossRefPubMed
67.
go back to reference I. Blumer, E. Hadar, D.R. Hadden, L. Jovanovic, J.H. Mestman, M.H. Murad, Y. Yogev for Endocrine Society, Diabetes and Pregnancy Clinical and Practice Guidelines–Endocrine Society. https://www.endocrine.org/~/media/endosociety/Files/Publications/ClinicalPracticeGuidelines/120513_DiabetesPregnancy_FinalD_2013.pdf+endocrine+society+gdm&tbo=1&sa=X&ved=0ahUKEwih6fijwPfTAhXLBcAKHeHcC9kQHwgwMAA (2013). Accessed 25 Mar 2017 I. Blumer, E. Hadar, D.R. Hadden, L. Jovanovic, J.H. Mestman, M.H. Murad, Y. Yogev for Endocrine Society, Diabetes and Pregnancy Clinical and Practice Guidelines–Endocrine Society. https://​www.​endocrine.​org/​~/​media/​endosociety/​Files/​Publications/​ClinicalPractice​Guidelines/​120513_​DiabetesPregnanc​y_​FinalD_​2013.​pdf+endocrine+so​ciety+gdm&​tbo=​1&​sa=​X&​ved=​0ahUKEwih6fijwPf​TAhXLBcAKHeHcC9k​QHwgwMAA (2013). Accessed 25 Mar 2017
68.
go back to reference Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 37(suppl 1), S1–S212 (2013) Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 37(suppl 1), S1–S212 (2013)
69.
go back to reference The American College of Obstetricians and Gynecologists, Practice bulletin no. 137: Gestational diabetes mellitus. Obstet Gynecol 122(2), 406–416 (2013)CrossRef The American College of Obstetricians and Gynecologists, Practice bulletin no. 137: Gestational diabetes mellitus. Obstet Gynecol 122(2), 406–416 (2013)CrossRef
71.
go back to reference American Diabetes Association, Standards of medical care in diabetes–2017, 2. Management of diabetes in pregnancy. Diabetes Care 40(Suppl 1), S114–S119 (2017)CrossRef American Diabetes Association, Standards of medical care in diabetes–2017, 2. Management of diabetes in pregnancy. Diabetes Care 40(Suppl 1), S114–S119 (2017)CrossRef
72.
go back to reference A. Ferrara, T. Peng, C. Kim, Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the translating research into action for diabetes (TRIAD) Study. Diabetes Care 32(2), 269–274 (2009)PubMedPubMedCentralCrossRef A. Ferrara, T. Peng, C. Kim, Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the translating research into action for diabetes (TRIAD) Study. Diabetes Care 32(2), 269–274 (2009)PubMedPubMedCentralCrossRef
73.
go back to reference K.J. Hunt, D.L. Conway, Who returns for postpartum glucose screening following gestational diabetes mellitus? Am. J. Obstet. Gynecol. 198(4), 404–406 (2008)PubMedPubMedCentralCrossRef K.J. Hunt, D.L. Conway, Who returns for postpartum glucose screening following gestational diabetes mellitus? Am. J. Obstet. Gynecol. 198(4), 404–406 (2008)PubMedPubMedCentralCrossRef
74.
go back to reference U.M. Schaefer-Graf, S. Klavehn, R. Hartmann, H. Kleinwechter, N. Demandt, M. Sorger, S.L. Kjos, K. Vetter, M. Abou-Dakn, How do we reduce the number of cases of missed postpartum diabetes in women with recent gestational diabetes mellitus? Diabetes Care 32(11), 1960–1964 (2009)PubMedPubMedCentralCrossRef U.M. Schaefer-Graf, S. Klavehn, R. Hartmann, H. Kleinwechter, N. Demandt, M. Sorger, S.L. Kjos, K. Vetter, M. Abou-Dakn, How do we reduce the number of cases of missed postpartum diabetes in women with recent gestational diabetes mellitus? Diabetes Care 32(11), 1960–1964 (2009)PubMedPubMedCentralCrossRef
75.
go back to reference H. Venkataraman, N. Sattar, P. Saravanan, Postnatal testing following gestational diabetes: time to replace the oral glucose tolerance test? Lancet Diabetes Endocrinol. 3(10), 754–756 (2015)PubMedCrossRef H. Venkataraman, N. Sattar, P. Saravanan, Postnatal testing following gestational diabetes: time to replace the oral glucose tolerance test? Lancet Diabetes Endocrinol. 3(10), 754–756 (2015)PubMedCrossRef
76.
go back to reference L.J. England, P.M. Dietz, T. Njoroge, W.M. Callaghan, C. Bruce, R.M. Buus, D.F. Williamson, Preventing type 2 diabetes: public health implications for women with a history of gestational diabetes mellitus. Am. J. Obstet. Gynecol. 200(4), 200–365, e1-8 (2009)CrossRef L.J. England, P.M. Dietz, T. Njoroge, W.M. Callaghan, C. Bruce, R.M. Buus, D.F. Williamson, Preventing type 2 diabetes: public health implications for women with a history of gestational diabetes mellitus. Am. J. Obstet. Gynecol. 200(4), 200–365, e1-8 (2009)CrossRef
77.
go back to reference A. Duke, C. Yap, R. Bradbury, T.M. Hng, C. Kim, A. Wansbrough, N.W. Cheung, The discordance between HbA1c and glucose tolerance testing for the postpartum exclusion of diabetes following gestational diabetes. Diabetes Res. Clin. Pract. 108(1), 72–77 (2015)PubMedCrossRef A. Duke, C. Yap, R. Bradbury, T.M. Hng, C. Kim, A. Wansbrough, N.W. Cheung, The discordance between HbA1c and glucose tolerance testing for the postpartum exclusion of diabetes following gestational diabetes. Diabetes Res. Clin. Pract. 108(1), 72–77 (2015)PubMedCrossRef
78.
go back to reference D. Dudzik, M. Zorawski, M. Skotnicki, W. Zarzycki, A. García, S. Angulo, M.P. Lorenzo, C. Barbas, M.P. Ramos, GC-MS based gestational diabetes mellitus longitudinal study: Identification of 2-and 3-hydroxybutyrate as potential prognostic biomarkers. J. Pharm. Biomed. Anal. S0731–7085(17) 30511–30513 (2017). doi:10.1016/j.jpba.2017.02.056 PubMedCrossRef D. Dudzik, M. Zorawski, M. Skotnicki, W. Zarzycki, A. García, S. Angulo, M.P. Lorenzo, C. Barbas, M.P. Ramos, GC-MS based gestational diabetes mellitus longitudinal study: Identification of 2-and 3-hydroxybutyrate as potential prognostic biomarkers. J. Pharm. Biomed. Anal. S0731–7085(17) 30511–30513 (2017). doi:10.​1016/​j.​jpba.​2017.​02.​056 PubMedCrossRef
79.
go back to reference T. Liu, J. Li, F. Xu, M. Wang, S. Ding, H. Xu, F. Dong, Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS. Anal. Bioanal. Chem. 408(4), 1125–1135 (2016)PubMedCrossRef T. Liu, J. Li, F. Xu, M. Wang, S. Ding, H. Xu, F. Dong, Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS. Anal. Bioanal. Chem. 408(4), 1125–1135 (2016)PubMedCrossRef
80.
go back to reference M. Roverso, M. Brioschi, C. Banfi, S. Visentin, S. Burlina, R. Seraglia, P. Traldi, A. Lapolla, A preliminary study on human placental tissue impaired by gestational diabetes: a comparison of gel-based versus gel-free proteomics approaches. Eur. J. Mass Spectrom. 22(2), 71–82 (2016)CrossRef M. Roverso, M. Brioschi, C. Banfi, S. Visentin, S. Burlina, R. Seraglia, P. Traldi, A. Lapolla, A preliminary study on human placental tissue impaired by gestational diabetes: a comparison of gel-based versus gel-free proteomics approaches. Eur. J. Mass Spectrom. 22(2), 71–82 (2016)CrossRef
81.
go back to reference A. Allalou, A. Nalla, K.J. Prentice, Y. Liu, M. Zhang, F.F. Dai, X. Ning, L.R. Osborne, B.J. Cox, E.P. Gunderson, M.B. Wheeler, A predictive metabolic signature for the transition from gestational diabetes mellitus to type 2 diabetes. Diabetes 65(9), 2529–2539 (2016)PubMedPubMedCentralCrossRef A. Allalou, A. Nalla, K.J. Prentice, Y. Liu, M. Zhang, F.F. Dai, X. Ning, L.R. Osborne, B.J. Cox, E.P. Gunderson, M.B. Wheeler, A predictive metabolic signature for the transition from gestational diabetes mellitus to type 2 diabetes. Diabetes 65(9), 2529–2539 (2016)PubMedPubMedCentralCrossRef
82.
go back to reference M. Ekelund, N. Shaat, P. Almgren, L. Groop, K. Berntorp, Prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetologia 53(3), 452–457 (2010)PubMedCrossRef M. Ekelund, N. Shaat, P. Almgren, L. Groop, K. Berntorp, Prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetologia 53(3), 452–457 (2010)PubMedCrossRef
83.
go back to reference C. Capula, E. Chiefari, A. Vero, S. Iiritano, B. Arcidiacono, L. Puccio, V. Pullano, D. Foti, A. Brunetti, R. Vero, Predictors of postpartum glucose tolerance testing in italian women with gestational diabetes mellitus. ISRN Endocrinol. 2013, 182505 (2013)PubMedPubMedCentral C. Capula, E. Chiefari, A. Vero, S. Iiritano, B. Arcidiacono, L. Puccio, V. Pullano, D. Foti, A. Brunetti, R. Vero, Predictors of postpartum glucose tolerance testing in italian women with gestational diabetes mellitus. ISRN Endocrinol. 2013, 182505 (2013)PubMedPubMedCentral
84.
go back to reference C.V. Almario, T. Ecker, L.A. Moroz, L. Bucovetsky, V. Berghella, J.K. Baxter, Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. Am. J. Obstet. Gynecol. 198(5), 528.e1–5 (2008)CrossRef C.V. Almario, T. Ecker, L.A. Moroz, L. Bucovetsky, V. Berghella, J.K. Baxter, Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. Am. J. Obstet. Gynecol. 198(5), 528.e1–5 (2008)CrossRef
85.
go back to reference O.S. Kerimoğlu, S. Yalvaç, D. Karçaaltınçaba, O. Kandemir, Incidence of diabetes mellitus at postpartum six to twelve months following the diagnosis of gestational diabetes mellitus. J. Turk. Ger. Gynecol. Assoc. 11(2), 89–94 (2010)PubMedPubMedCentralCrossRef O.S. Kerimoğlu, S. Yalvaç, D. Karçaaltınçaba, O. Kandemir, Incidence of diabetes mellitus at postpartum six to twelve months following the diagnosis of gestational diabetes mellitus. J. Turk. Ger. Gynecol. Assoc. 11(2), 89–94 (2010)PubMedPubMedCentralCrossRef
86.
go back to reference S. Kwong, R.S. Mitchell, P.A. Senior, C.L. Chik, Postpartum diabetes screening: adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test. Diabetes Care 32(12), 2242–2244 (2009)PubMedPubMedCentralCrossRef S. Kwong, R.S. Mitchell, P.A. Senior, C.L. Chik, Postpartum diabetes screening: adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test. Diabetes Care 32(12), 2242–2244 (2009)PubMedPubMedCentralCrossRef
87.
go back to reference J.M. Lawrence, M.H. Black, J.W. Hsu, W. Chen, D.A. Sacks, Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus. Diabetes Care 33(3), 569–576 (2010)PubMedCrossRef J.M. Lawrence, M.H. Black, J.W. Hsu, W. Chen, D.A. Sacks, Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus. Diabetes Care 33(3), 569–576 (2010)PubMedCrossRef
88.
go back to reference J. Ogonowski, T. Miazgowski, The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes. Diabetes Res. Clin. Pract. 84(3), 239–244 (2009)PubMedCrossRef J. Ogonowski, T. Miazgowski, The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes. Diabetes Res. Clin. Pract. 84(3), 239–244 (2009)PubMedCrossRef
89.
go back to reference M. Stasenko, Y.W. Cheng, T. McLean, A.C. Jelin, L. Rand, A.B. Caughey, Postpartum follow-up for women with gestational diabetes mellitus. Am. J. Perinatol. 27(9), 737–742 (2010)PubMedCrossRef M. Stasenko, Y.W. Cheng, T. McLean, A.C. Jelin, L. Rand, A.B. Caughey, Postpartum follow-up for women with gestational diabetes mellitus. Am. J. Perinatol. 27(9), 737–742 (2010)PubMedCrossRef
90.
go back to reference O.S. Kerimoğlu, S. Yalvac, D. Karcaaltincaba, O. Kandemir, S.K. Altınbaş, H. Dede, Early post-partum diabetes mellitus screening rates in patients with history of gestational diabetes. Arch. Gynecol. Obstet. 282(6), 613–616 (2010)PubMedCrossRef O.S. Kerimoğlu, S. Yalvac, D. Karcaaltincaba, O. Kandemir, S.K. Altınbaş, H. Dede, Early post-partum diabetes mellitus screening rates in patients with history of gestational diabetes. Arch. Gynecol. Obstet. 282(6), 613–616 (2010)PubMedCrossRef
91.
go back to reference L.S. Weinert, L.S. Mastella, M.L. Oppermann, S.P. Silveiro, L.S. Guimarães, A.J. Reichelt, Postpartum glucose tolerance status 6 to 12 weeks after gestational diabetes mellitus: a Brazilian cohort. Arq. Bras. Endocrinol. Metabol. 58(2), 197–204 (2014)PubMedCrossRef L.S. Weinert, L.S. Mastella, M.L. Oppermann, S.P. Silveiro, L.S. Guimarães, A.J. Reichelt, Postpartum glucose tolerance status 6 to 12 weeks after gestational diabetes mellitus: a Brazilian cohort. Arq. Bras. Endocrinol. Metabol. 58(2), 197–204 (2014)PubMedCrossRef
92.
go back to reference E. Cosson, H. Bihan, L. Vittaz, C. Khiter, L. Carbillon, F. Faghfouri, D. Leboeuf, H. Dauphin, A. Lepagnol, G. Reach, P. Valensi, Improving postpartum glucose screening after gestational diabetes mellitus: a cohort study to evaluate the multicentre IMPACT initiative. Diabet. Med. 32(2), 189–197 (2015)PubMedCrossRef E. Cosson, H. Bihan, L. Vittaz, C. Khiter, L. Carbillon, F. Faghfouri, D. Leboeuf, H. Dauphin, A. Lepagnol, G. Reach, P. Valensi, Improving postpartum glucose screening after gestational diabetes mellitus: a cohort study to evaluate the multicentre IMPACT initiative. Diabet. Med. 32(2), 189–197 (2015)PubMedCrossRef
93.
go back to reference C. Chamberlain, A. McLean, J. Oats, B. Oldenburg, S. Eades, A. Sinha, R. Wolfe, Low rates of postpartum glucose screening among indigenous and non-indigenous women in Australia with gestational diabetes. Matern. Child. Health J. 19(3), 651–663 (2015)PubMedCrossRef C. Chamberlain, A. McLean, J. Oats, B. Oldenburg, S. Eades, A. Sinha, R. Wolfe, Low rates of postpartum glucose screening among indigenous and non-indigenous women in Australia with gestational diabetes. Matern. Child. Health J. 19(3), 651–663 (2015)PubMedCrossRef
94.
go back to reference E. Korpi-Hyovalti, D.E. Laaksonen, U. Schwab, S. Heinonen, L. Niskanen, How can we increase postpartum glucose screening in women at high risk for gestational diabetes mellitus? Int. J. Endocrinol. 2012, 519267 (2012)PubMedPubMedCentralCrossRef E. Korpi-Hyovalti, D.E. Laaksonen, U. Schwab, S. Heinonen, L. Niskanen, How can we increase postpartum glucose screening in women at high risk for gestational diabetes mellitus? Int. J. Endocrinol. 2012, 519267 (2012)PubMedPubMedCentralCrossRef
95.
go back to reference J.W. Tang, K.E. Foster, J. Pumarino, R.T. Ackermann, A.M. Peaceman, K.A. Cameron, Perspectives on prevention of type 2 diabetes after gestational diabetes: a qualitative study of Hispanic, African-American and White women. Matern. Child. Health J. 19(7), 1526–1534 (2015)PubMedCrossRef J.W. Tang, K.E. Foster, J. Pumarino, R.T. Ackermann, A.M. Peaceman, K.A. Cameron, Perspectives on prevention of type 2 diabetes after gestational diabetes: a qualitative study of Hispanic, African-American and White women. Matern. Child. Health J. 19(7), 1526–1534 (2015)PubMedCrossRef
96.
go back to reference A.M. Baker, S.C. Brody, K. Salisbury, R. Schectman, K.E. Hartmann, Postpartum glucose tolerance screening in women with gestational diabetes in the state of North Carolina. N. C. Med. J. 70(1), 14–19 (2009)PubMed A.M. Baker, S.C. Brody, K. Salisbury, R. Schectman, K.E. Hartmann, Postpartum glucose tolerance screening in women with gestational diabetes in the state of North Carolina. N. C. Med. J. 70(1), 14–19 (2009)PubMed
97.
go back to reference Y. Gupta, A. Gupta, Post-partum screening after gestational diabetes. Lancet Diabetes Endocrinol. 1(2), 90–101 (2013)PubMedCrossRef Y. Gupta, A. Gupta, Post-partum screening after gestational diabetes. Lancet Diabetes Endocrinol. 1(2), 90–101 (2013)PubMedCrossRef
98.
go back to reference A.M. Stuebe, J.W. Rich-Edwards, W.C. Willett, J.E. Manson, K.B. Michels, Duration of lactation and incidence of type 2 diabetes. JAMA 294(20), 2601–2610 (2005)PubMedCrossRef A.M. Stuebe, J.W. Rich-Edwards, W.C. Willett, J.E. Manson, K.B. Michels, Duration of lactation and incidence of type 2 diabetes. JAMA 294(20), 2601–2610 (2005)PubMedCrossRef
99.
go back to reference S. Aziz, T.F. Munim, S.S. Fatima, Post-partum follow-up of women with gestational diabetes mellitus: effectiveness, determinants, and barriers. J. Matern. Fetal. Neonatal. Med. 5, 1–6 (2017) S. Aziz, T.F. Munim, S.S. Fatima, Post-partum follow-up of women with gestational diabetes mellitus: effectiveness, determinants, and barriers. J. Matern. Fetal. Neonatal. Med. 5, 1–6 (2017)
100.
go back to reference K.K. Nielsen, A. Kapur, P. Damm, M. de Courten, I.C. Bygbjerg, From screening to postpartum follow-up - the determinants and barriers for gestational diabetes mellitus (GDM) services, a systematic review. BMC Pregnancy Childbirth 22, 14–41 (2014) K.K. Nielsen, A. Kapur, P. Damm, M. de Courten, I.C. Bygbjerg, From screening to postpartum follow-up - the determinants and barriers for gestational diabetes mellitus (GDM) services, a systematic review. BMC Pregnancy Childbirth 22, 14–41 (2014)
101.
go back to reference J.A. Bernstein, L. McCloskey, C.M. Gebel, R.E. Iverson, A. Lee-Parritz, Lost opportunities to prevent early onset type 2 diabetes mellitus after a pregnancy complicated by gestational diabetes. BMJ Open Diabetes Res. Care. 4(1), e000250 (2016)PubMedPubMedCentralCrossRef J.A. Bernstein, L. McCloskey, C.M. Gebel, R.E. Iverson, A. Lee-Parritz, Lost opportunities to prevent early onset type 2 diabetes mellitus after a pregnancy complicated by gestational diabetes. BMJ Open Diabetes Res. Care. 4(1), e000250 (2016)PubMedPubMedCentralCrossRef
102.
go back to reference M. Pierce, J. Modder, I. Mortagy, A. Springett, H. Hughes, S. Baldeweg, Missed opportunities for diabetes prevention: post-pregnancy follow-up of women with gestational diabetes mellitus in England. Br. J. Gen. Pract. 61(591), e611–e619 (2011)PubMedPubMedCentralCrossRef M. Pierce, J. Modder, I. Mortagy, A. Springett, H. Hughes, S. Baldeweg, Missed opportunities for diabetes prevention: post-pregnancy follow-up of women with gestational diabetes mellitus in England. Br. J. Gen. Pract. 61(591), e611–e619 (2011)PubMedPubMedCentralCrossRef
104.
go back to reference I.C. Lega, H. McLaughlin, M. Coroneos, F. Handley-Derry, N. Donovan, L.L. Lipscombe, A physician reminder to improve postpartum diabetes screening in women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 95(3), 352–735 (2012)PubMedCrossRef I.C. Lega, H. McLaughlin, M. Coroneos, F. Handley-Derry, N. Donovan, L.L. Lipscombe, A physician reminder to improve postpartum diabetes screening in women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 95(3), 352–735 (2012)PubMedCrossRef
105.
go back to reference I.J. Halperin, P. Sehgal, J. Lowe, M. Hladunewich, B.M. Wong, Increasing timely postpartum oral glucose tolerance test completion in women with gestational diabetes: a quality-improvement initiative. Can. J. Diabetes 39(6), 451–456 (2015)PubMedCrossRef I.J. Halperin, P. Sehgal, J. Lowe, M. Hladunewich, B.M. Wong, Increasing timely postpartum oral glucose tolerance test completion in women with gestational diabetes: a quality-improvement initiative. Can. J. Diabetes 39(6), 451–456 (2015)PubMedCrossRef
106.
go back to reference H.D. Clark, I.D. Graham, A. Karovitch, E.J. Keely, Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am. J. Obstet. Gynecol. 200(6), 634.e1–7 (2009)CrossRef H.D. Clark, I.D. Graham, A. Karovitch, E.J. Keely, Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am. J. Obstet. Gynecol. 200(6), 634.e1–7 (2009)CrossRef
107.
go back to reference E. Heatley, P. Middleton, W. Hague, C. Crowther, The DIAMIND study: postpartum SMS reminders to women who have had gestational diabetes mellitus to test for type 2 diabetes: a randomised controlled trial - study protocol. BMC Pregnancy Childbirth 13, 92 (2013)PubMedPubMedCentralCrossRef E. Heatley, P. Middleton, W. Hague, C. Crowther, The DIAMIND study: postpartum SMS reminders to women who have had gestational diabetes mellitus to test for type 2 diabetes: a randomised controlled trial - study protocol. BMC Pregnancy Childbirth 13, 92 (2013)PubMedPubMedCentralCrossRef
108.
go back to reference K.K. Vesco, P.M. Dietz, J. Bulkley, F.C. Bruce, W.M. Callaghan, L. England, T. Kimes, D.J. Bachman, K.J. Hartinger, M.C. Hornbrook, A system-based intervention to improve postpartum diabetes screening among women with gestational diabetes. Am. J. Obstet. Gynecol. 207(4), 283.e1–6 (2012)CrossRef K.K. Vesco, P.M. Dietz, J. Bulkley, F.C. Bruce, W.M. Callaghan, L. England, T. Kimes, D.J. Bachman, K.J. Hartinger, M.C. Hornbrook, A system-based intervention to improve postpartum diabetes screening among women with gestational diabetes. Am. J. Obstet. Gynecol. 207(4), 283.e1–6 (2012)CrossRef
109.
go back to reference M. Stasenko, J. Liddell, Y.W. Cheng, T.N. Sparks, M. Killion, A.B. Caughey, Patient counseling increases postpartum follow-up in women with gestational diabetes mellitus. Am. J. Obstet. Gynecol. 204(6), 522.e1–6 (2011)CrossRef M. Stasenko, J. Liddell, Y.W. Cheng, T.N. Sparks, M. Killion, A.B. Caughey, Patient counseling increases postpartum follow-up in women with gestational diabetes mellitus. Am. J. Obstet. Gynecol. 204(6), 522.e1–6 (2011)CrossRef
110.
go back to reference M.A. Mohd Suan, Return for postpartum oral glucose tolerance test following gestational diabetes mellitus. Asia Pac. J. Public Health 27(6), 601–609 (2015)PubMedCrossRef M.A. Mohd Suan, Return for postpartum oral glucose tolerance test following gestational diabetes mellitus. Asia Pac. J. Public Health 27(6), 601–609 (2015)PubMedCrossRef
111.
go back to reference B. Olowokure, M. Caswell, H.V. Duggal, What women want: convenient appointment times for cervical screening tests. Eur. J. Cancer Care 15(5), 489–492 (2006)CrossRef B. Olowokure, M. Caswell, H.V. Duggal, What women want: convenient appointment times for cervical screening tests. Eur. J. Cancer Care 15(5), 489–492 (2006)CrossRef
112.
go back to reference M. Trigoni, F. Griffiths, D. Tsiftsis, E. Koumantakis, E. Green, C. Lionis, Mammography screening: views from women and primary care physicians in Crete. BMC Womens Health 8, 20 (2008)PubMedPubMedCentralCrossRef M. Trigoni, F. Griffiths, D. Tsiftsis, E. Koumantakis, E. Green, C. Lionis, Mammography screening: views from women and primary care physicians in Crete. BMC Womens Health 8, 20 (2008)PubMedPubMedCentralCrossRef
113.
go back to reference D.K. Tobias, F.B. Hu, J. Chavarro, B. Rosner, D. Mozaffarian, C. Zhang, Healthful dietary patterns and type 2 diabetes mellitus risk among women with a history of gestational diabetes mellitus. Arch. Intern. Med. 172(20), 1566–1572 (2012)PubMedPubMedCentralCrossRef D.K. Tobias, F.B. Hu, J. Chavarro, B. Rosner, D. Mozaffarian, C. Zhang, Healthful dietary patterns and type 2 diabetes mellitus risk among women with a history of gestational diabetes mellitus. Arch. Intern. Med. 172(20), 1566–1572 (2012)PubMedPubMedCentralCrossRef
114.
go back to reference S.H. Koning, H.L. Lutgers, K. Hoogenberg, C.A. Trompert, P.P. van den Berg, B.H. Wolffenbuttel, Postpartum glucose follow-up and lifestyle management after gestational diabetes mellitus: general practitioner and patient perspectives. J. Diabetes Metab. Disord. 15, 56 (2016)PubMedPubMedCentralCrossRef S.H. Koning, H.L. Lutgers, K. Hoogenberg, C.A. Trompert, P.P. van den Berg, B.H. Wolffenbuttel, Postpartum glucose follow-up and lifestyle management after gestational diabetes mellitus: general practitioner and patient perspectives. J. Diabetes Metab. Disord. 15, 56 (2016)PubMedPubMedCentralCrossRef
115.
go back to reference V.R. Aroda, C.A. Christophi, S.L. Edelstein, P. Zhang, W.H. Herman, E. Barrett-Connor, L.M. Delahanty, M.G. Montez, R.T. Ackermann, X. Zhuo, W.C. Knowler, R.E. Ratner; Diabetes Prevention Program Research Group, The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the diabetes prevention program outcomes study 10-year follow-up. J. Clin. Endocrinol. Metab. 100(4), 1646–1653 (2015)PubMedPubMedCentralCrossRef V.R. Aroda, C.A. Christophi, S.L. Edelstein, P. Zhang, W.H. Herman, E. Barrett-Connor, L.M. Delahanty, M.G. Montez, R.T. Ackermann, X. Zhuo, W.C. Knowler, R.E. Ratner; Diabetes Prevention Program Research Group, The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the diabetes prevention program outcomes study 10-year follow-up. J. Clin. Endocrinol. Metab. 100(4), 1646–1653 (2015)PubMedPubMedCentralCrossRef
116.
go back to reference S.J. Gardiner, C.M. Kirkpatrick, E.J. Begg, M. Zhang, M.P. Moore, D.J. Saville, Transfer of metformin into human milk. Clin. Pharmacol. Ther. 73(1), 71–77 (2003)PubMedCrossRef S.J. Gardiner, C.M. Kirkpatrick, E.J. Begg, M. Zhang, M.P. Moore, D.J. Saville, Transfer of metformin into human milk. Clin. Pharmacol. Ther. 73(1), 71–77 (2003)PubMedCrossRef
117.
go back to reference G.G. Briggs, P.J. Ambrose, M.P. Nageotte, G. Padilla, S. Wan, Excretion of metformin into breast milk and the effect on nursing infants. Obstet. Gynecol. 105(6), 1437–1441 (2005)PubMedCrossRef G.G. Briggs, P.J. Ambrose, M.P. Nageotte, G. Padilla, S. Wan, Excretion of metformin into breast milk and the effect on nursing infants. Obstet. Gynecol. 105(6), 1437–1441 (2005)PubMedCrossRef
118.
go back to reference T.W. Hale, J.H. Kristensen, L.P. Hackett, R. Kohan, K.F. Ilett, Transfer of metformin into human milk. Diabetologia 45(11), 1509–1514 (2002)PubMedCrossRef T.W. Hale, J.H. Kristensen, L.P. Hackett, R. Kohan, K.F. Ilett, Transfer of metformin into human milk. Diabetologia 45(11), 1509–1514 (2002)PubMedCrossRef
119.
go back to reference S. Morton, S. Kirkwood, S. Thangaratinam, Interventions to modify the progression to type 2 diabetes mellitus in women with gestational diabetes: a systematic review of literature. Curr. Opin. Obstet. Gynecol. 26(6), 476–486 (2014)PubMedCrossRef S. Morton, S. Kirkwood, S. Thangaratinam, Interventions to modify the progression to type 2 diabetes mellitus in women with gestational diabetes: a systematic review of literature. Curr. Opin. Obstet. Gynecol. 26(6), 476–486 (2014)PubMedCrossRef
120.
go back to reference U.M. Schaefer, G. Songster, A. Xiang, K. Berkowitz, T.A. Buchanan, S.L. Kjos, Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am. J. Obstet. Gynecol. 177(5), 1165–1171 (1997)PubMedCrossRef U.M. Schaefer, G. Songster, A. Xiang, K. Berkowitz, T.A. Buchanan, S.L. Kjos, Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am. J. Obstet. Gynecol. 177(5), 1165–1171 (1997)PubMedCrossRef
121.
go back to reference K. Benhalima, K. Jegers, R. Devlieger, J. Verhaeghe, C. Mathieu, Glucose intolerance after a recent history of gestational diabetes based on the 2013 WHO criteria. PLoS ONE 11(6), e0157272 (2016)PubMedPubMedCentralCrossRef K. Benhalima, K. Jegers, R. Devlieger, J. Verhaeghe, C. Mathieu, Glucose intolerance after a recent history of gestational diabetes based on the 2013 WHO criteria. PLoS ONE 11(6), e0157272 (2016)PubMedPubMedCentralCrossRef
122.
go back to reference K. Benhalima, L. Leuridan, P. Calewaert, R. Devlieger, J. Verhaeghe, C. Mathieu, Glucose intolerance after a recent history of gestational diabetes. Int. J. Endocrinol. 2014, 727652 (2014)PubMedPubMedCentralCrossRef K. Benhalima, L. Leuridan, P. Calewaert, R. Devlieger, J. Verhaeghe, C. Mathieu, Glucose intolerance after a recent history of gestational diabetes. Int. J. Endocrinol. 2014, 727652 (2014)PubMedPubMedCentralCrossRef
123.
go back to reference B. Bhavadharini, R.M. Anjana, M.M. Mahalakshmi, K. Maheswari, A. Kayal, R. Unnikrishnan, H. Ranjani, L. Ninov, S.D. Pastakia, S. Usha, B. Malanda, A. Belton, R. Uma, V. Mohan, Glucose tolerance status of Asian Indian women with gestational diabetes at 6 weeks to 1 year postpartum (WINGS-7). Diabetes Res. Clin. Pract. 117, 22–27 (2016)PubMedCrossRef B. Bhavadharini, R.M. Anjana, M.M. Mahalakshmi, K. Maheswari, A. Kayal, R. Unnikrishnan, H. Ranjani, L. Ninov, S.D. Pastakia, S. Usha, B. Malanda, A. Belton, R. Uma, V. Mohan, Glucose tolerance status of Asian Indian women with gestational diabetes at 6 weeks to 1 year postpartum (WINGS-7). Diabetes Res. Clin. Pract. 117, 22–27 (2016)PubMedCrossRef
124.
go back to reference G.J. Cho, J.J. An, S.J. Choi, S.Y. Oh, H.S. Kwon, S.C. Hong, J.Y. Kwon, Postpartum glucose testing rates following gestational diabetes mellitus and factors affecting testing non-compliance from four tertiary centers in Korea. J. Korean Med. Sci. 30(12), 1841–1846 (2015)PubMedPubMedCentralCrossRef G.J. Cho, J.J. An, S.J. Choi, S.Y. Oh, H.S. Kwon, S.C. Hong, J.Y. Kwon, Postpartum glucose testing rates following gestational diabetes mellitus and factors affecting testing non-compliance from four tertiary centers in Korea. J. Korean Med. Sci. 30(12), 1841–1846 (2015)PubMedPubMedCentralCrossRef
125.
go back to reference H. Ghajari, S. Nouhjah, H. Shahbazian, R. Valizadeh, N. Tahery, Postpartum glucose testing, related factors and progression to abnormal glucose tolerance in a rural population with a known history of gestational diabetes. Diabetes Metab. Syndr. (2017). doi:10.1016/j.dsx.2017.03.035 CrossRef H. Ghajari, S. Nouhjah, H. Shahbazian, R. Valizadeh, N. Tahery, Postpartum glucose testing, related factors and progression to abnormal glucose tolerance in a rural population with a known history of gestational diabetes. Diabetes Metab. Syndr. (2017). doi:10.​1016/​j.​dsx.​2017.​03.​035 CrossRef
126.
go back to reference J. Katon, G. Reiber, M.A. Williams, D. Yanez, E. Miller, Hemoglobin A1c and postpartum abnormal glucose tolerance among women with gestational diabetes mellitus. Obstet. Gynecol. 119(3), 566–574 (2012)PubMedPubMedCentralCrossRef J. Katon, G. Reiber, M.A. Williams, D. Yanez, E. Miller, Hemoglobin A1c and postpartum abnormal glucose tolerance among women with gestational diabetes mellitus. Obstet. Gynecol. 119(3), 566–574 (2012)PubMedPubMedCentralCrossRef
127.
go back to reference S.H. Kwak, S.H. Choi, H.S. Jung, Y.M. Cho, S. Lim, N.H. Cho, S.Y. Kim, K.S. Park, H.C. Jang, Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 98(4), E744–E752 (2013)PubMedCrossRef S.H. Kwak, S.H. Choi, H.S. Jung, Y.M. Cho, S. Lim, N.H. Cho, S.Y. Kim, K.S. Park, H.C. Jang, Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 98(4), E744–E752 (2013)PubMedCrossRef
128.
go back to reference H. Mendez-Figueroa, J.D. Dahlke, J. Daley, V.V. Lopes, D.R. Coustan, Prediction of abnormal postpartum glucose tolerance testing in mild gestational diabetes mellitus. J. Reprod. Med. 59(7-8), 393–400 (2014)PubMed H. Mendez-Figueroa, J.D. Dahlke, J. Daley, V.V. Lopes, D.R. Coustan, Prediction of abnormal postpartum glucose tolerance testing in mild gestational diabetes mellitus. J. Reprod. Med. 59(7-8), 393–400 (2014)PubMed
129.
go back to reference S. Nouhjah, H. Shahbazian, N. Shahbazian, A. Jahanshahi, S. Jahanfar, B. Cheraghian, Incidence and contributing factors of persistent hyperglycemia at 6-12 weeks postpartum in Iranian women with gestational diabetes: results from LAGA cohort study. J. Diabetes Res. 2017, 9786436 (2017)PubMedPubMedCentralCrossRef S. Nouhjah, H. Shahbazian, N. Shahbazian, A. Jahanshahi, S. Jahanfar, B. Cheraghian, Incidence and contributing factors of persistent hyperglycemia at 6-12 weeks postpartum in Iranian women with gestational diabetes: results from LAGA cohort study. J. Diabetes Res. 2017, 9786436 (2017)PubMedPubMedCentralCrossRef
130.
go back to reference E. Noctor, C. Crowe, L.A. Carmody, J.A. Saunders, B. Kirwan, A. O’Dea, P. Gillespie, L.G. Glynn, B.E. McGuire, C. O’Neill, P.M. O’Shea, F.P. Dunne, ATLANTIC-DIP investigators, abnormal glucose tolerance post-gestational diabetes mellitus as defined by the international association of diabetes and pregnancy study groups criteria. Eur. J. Endocrinol. 175(4), 287–297 (2016)PubMedCrossRef E. Noctor, C. Crowe, L.A. Carmody, J.A. Saunders, B. Kirwan, A. O’Dea, P. Gillespie, L.G. Glynn, B.E. McGuire, C. O’Neill, P.M. O’Shea, F.P. Dunne, ATLANTIC-DIP investigators, abnormal glucose tolerance post-gestational diabetes mellitus as defined by the international association of diabetes and pregnancy study groups criteria. Eur. J. Endocrinol. 175(4), 287–297 (2016)PubMedCrossRef
131.
go back to reference M.A. Russell, M.G. Phipps, C.L. Olson, H.G. Welch, M.W. Carpenter, Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet. Gynecol. 108, 1456–1462 (2006)PubMedCrossRef M.A. Russell, M.G. Phipps, C.L. Olson, H.G. Welch, M.W. Carpenter, Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet. Gynecol. 108, 1456–1462 (2006)PubMedCrossRef
132.
go back to reference U.M. Schaefer-Graf, T.A. Buchanan, A. Xiang, R.K. Peters, S.L. Kjos, Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am. J. Obstet. Gynecol. 186, 751–756 (2002)PubMedCrossRef U.M. Schaefer-Graf, T.A. Buchanan, A. Xiang, R.K. Peters, S.L. Kjos, Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am. J. Obstet. Gynecol. 186, 751–756 (2002)PubMedCrossRef
133.
go back to reference I.P. Mathieu, Y. Song, S.M. Jagasia, Disparities in postpartum follow-up in women with gestational diabetes mellitus. Clin. Diabetes 32(4), 178–182 (2014)PubMedPubMedCentralCrossRef I.P. Mathieu, Y. Song, S.M. Jagasia, Disparities in postpartum follow-up in women with gestational diabetes mellitus. Clin. Diabetes 32(4), 178–182 (2014)PubMedPubMedCentralCrossRef
134.
go back to reference L. McCloskey, J. Bernstein, M. Winter, R. Iverson, A. Lee-Parritz, Follow-up of gestational diabetes mellitus in an urban safety net hospital: missed opportunities to launch preventive care for women. J. Womens Health 23(4), 327–334 (2014)CrossRef L. McCloskey, J. Bernstein, M. Winter, R. Iverson, A. Lee-Parritz, Follow-up of gestational diabetes mellitus in an urban safety net hospital: missed opportunities to launch preventive care for women. J. Womens Health 23(4), 327–334 (2014)CrossRef
135.
go back to reference A. McGovern, L. Butler, S. Jones, J. van Vlymen, K. Sadek, N. Munro, H. Carr, S. de Lusignan, Diabetes screening after gestational diabetes in England: a quantitative retrospective cohort study. Br. J. Gen. Pract. 64(618), e17–e23 (2014)PubMedCrossRef A. McGovern, L. Butler, S. Jones, J. van Vlymen, K. Sadek, N. Munro, H. Carr, S. de Lusignan, Diabetes screening after gestational diabetes in England: a quantitative retrospective cohort study. Br. J. Gen. Pract. 64(618), e17–e23 (2014)PubMedCrossRef
136.
go back to reference P. Peticca, B.R. Shah, A. Shea, H.D. Clark, J.C. Malcolm, M. Walker, A. Karovitch, P. Brazeau-Gravelle, E.J. Keely, Clinical predictors for diabetes screening in the first year postpartum after gestational diabetes. Obstet. Med 7(3), 116–120 (2014)PubMedPubMedCentralCrossRef P. Peticca, B.R. Shah, A. Shea, H.D. Clark, J.C. Malcolm, M. Walker, A. Karovitch, P. Brazeau-Gravelle, E.J. Keely, Clinical predictors for diabetes screening in the first year postpartum after gestational diabetes. Obstet. Med 7(3), 116–120 (2014)PubMedPubMedCentralCrossRef
137.
go back to reference W.E. Swan, S.T. Liaw, T. Dunning, J.F. Pallant, G. Kilmartin, Diabetes risk reduction behaviours of rural postpartum women with a recent history of gestational diabetes. Rural. Remote Health 10(4), 1461 (2010)PubMed W.E. Swan, S.T. Liaw, T. Dunning, J.F. Pallant, G. Kilmartin, Diabetes risk reduction behaviours of rural postpartum women with a recent history of gestational diabetes. Rural. Remote Health 10(4), 1461 (2010)PubMed
138.
go back to reference L. Carmody, A.M. Egan, F.P. Dunne, Postpartum glucose testing for women with gestational diabetes mellitus: Improving regional recall rates. Diabetes Res. Clin. Pract. 108(3), e38–e41 (2015)PubMedCrossRef L. Carmody, A.M. Egan, F.P. Dunne, Postpartum glucose testing for women with gestational diabetes mellitus: Improving regional recall rates. Diabetes Res. Clin. Pract. 108(3), e38–e41 (2015)PubMedCrossRef
139.
go back to reference M.P. Carson, M.I. Frank, E. Keely, Original research: postpartum testing rates among women with a history of gestational diabetes--systematic review. Prim. Care. Diabetes 7(3), 177–186 (2013) M.P. Carson, M.I. Frank, E. Keely, Original research: postpartum testing rates among women with a history of gestational diabetes--systematic review. Prim. Care. Diabetes 7(3), 177–186 (2013)
140.
go back to reference R. Khorshidi Roozbahani, M. Geranmayeh, S. Hantoushzadeh, A. Mehran, Effects of telephone follow-up on blood glucose levels and postpartum screeningin mothers with gestational diabetes mellitus. Med. J. Islam. Repub. Iran 29, 249 (2015)PubMedPubMedCentral R. Khorshidi Roozbahani, M. Geranmayeh, S. Hantoushzadeh, A. Mehran, Effects of telephone follow-up on blood glucose levels and postpartum screeningin mothers with gestational diabetes mellitus. Med. J. Islam. Repub. Iran 29, 249 (2015)PubMedPubMedCentral
141.
go back to reference E. Van Ryswyk, P. Middleton, W. Hague, C. Crowther, Clinician views and knowledge regarding healthcare provision in the postpartum period for women with recent gestational diabetes: a systematic review of qualitative/survey studies. Diabetes Res. Clin. Pract. 106(3), 401–411 (2014)PubMedCrossRef E. Van Ryswyk, P. Middleton, W. Hague, C. Crowther, Clinician views and knowledge regarding healthcare provision in the postpartum period for women with recent gestational diabetes: a systematic review of qualitative/survey studies. Diabetes Res. Clin. Pract. 106(3), 401–411 (2014)PubMedCrossRef
142.
go back to reference A.K. Shea, B.R. Shah, H.D. Clark, J. Malcolm, M. Walker, A. Karovitch, E.J. Keely, The effectiveness of implementing a reminder system into routine clinical practice: does it increase postpartum screening in women with gestational diabetes? Chronic Dis. Can. 31(2), 58–64 (2011)PubMedCrossRef A.K. Shea, B.R. Shah, H.D. Clark, J. Malcolm, M. Walker, A. Karovitch, E.J. Keely, The effectiveness of implementing a reminder system into routine clinical practice: does it increase postpartum screening in women with gestational diabetes? Chronic Dis. Can. 31(2), 58–64 (2011)PubMedCrossRef
143.
go back to reference M.D. Soffer, S.H. Factor, A. Rosenman, C. Levy, J. Stone, Improving postpartum glucose monitoring in women with gestational diabetes. J. Matern. Fetal. Neonatal. Med. 12, 1–6 (2017) M.D. Soffer, S.H. Factor, A. Rosenman, C. Levy, J. Stone, Improving postpartum glucose monitoring in women with gestational diabetes. J. Matern. Fetal. Neonatal. Med. 12, 1–6 (2017)
Metadata
Title
Postpartum glucose intolerance: an updated overview
Authors
Ida Pastore
Eusebio Chiefari
Raffaella Vero
Antonio Brunetti
Publication date
01-03-2018
Publisher
Springer US
Published in
Endocrine / Issue 3/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1388-0

Other articles of this Issue 3/2018

Endocrine 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine